Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CBFA2T2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
STK17A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB22A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STYXL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NSUN5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PROSC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SH3BP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACOX1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARNTL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKIRIN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARID1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL27RA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6513 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BBS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSME4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on